Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 24, 2015; 5(4): 287-291
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.287
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.287
Cytomegalovirus infection in the bone marrow transplant patient
Vivek Bhat, Amit Joshi, Preeti Chavan, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai 410210, India
Rahul Sarode, Tata Memorial Hospital, Navi Mumbai 410210, India
Author contributions: Bhat V and Sarode R wrote the manuscript; Joshi A and Chavan P edited and finalised the manuscript.
Conflict-of-interest statement: The authors declare no conflicts of interest regarding this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Amit Joshi, MD, DM, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Dr. E Borges Road, Parel, Navi Mumbai 410210, India. dramit74@yahoo.com
Telephone: +91-22-27405000 Fax: +91-22-27405093
Received: June 5, 2015
Peer-review started: June 5, 2015
First decision: August 10, 2015
Revised: October 17, 2015
Accepted: November 13, 2015
Article in press: November 17, 2015
Published online: December 24, 2015
Processing time: 201 Days and 11.8 Hours
Peer-review started: June 5, 2015
First decision: August 10, 2015
Revised: October 17, 2015
Accepted: November 13, 2015
Article in press: November 17, 2015
Published online: December 24, 2015
Processing time: 201 Days and 11.8 Hours
Core Tip
Core tip: Cytomegalovirus (CMV) infection and CMV disease may be associated with serious complications in the bone marrow transplant patient. The most commonly used test to monitor CMV replication is the CMV DNA polymerase chain reaction assay and serves a guide for preemptive therapy. Gancyclovir followed by foscarnet are most commonly used in CMV management.